Cross-Border SPC Strategy: Lessons from the Entresto UK Ruling

The UK High Court ruling in favour of Novartis' Entresto patent highlights that supplementary protection certificates (SPCs) grant country-specific exclusivity beyond patent expiry, meaning pharmaceutical patent and SPC strategies must be managed on a country-by-country basis rather than as a unified European approach.

This Wire brief sits within Fusion42's coverage of Drug Discovery.